Profile data is unavailable for this security.
About the company
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
- Revenue in CHF (TTM)2.41bn
- Net income in CHF246.07m
- Incorporated2005
- Employees11.11k
- LocationStraumann Holding AGPeter Merian-Weg 12BASEL 4002SwitzerlandCHE
- Phone+41 619651111
- Fax+41 619651101
- Websitehttps://www.straumann.com/
More ▼
Mergers & acquisitions
| Acquired company | STMN:SWX since announced | Transaction value |
|---|---|---|
| Alliedstar Medical Equipment Co Ltd | -3.91% | -- |
| Gravitonas UAB | -12.89% | -- |
| Med Grupe | -12.89% | -- |
| GalvoSurge Dental AG | -6.36% | -- |
Data delayed at least 15 minutes, as of Apr 30 2024 16:38 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ypsomed Holding AG | 508.61m | 72.42m | 4.49bn | 2.20k | 61.94 | 7.83 | 30.04 | 8.83 | 5.31 | 5.31 | 37.31 | 42.03 | 0.5888 | 4.92 | 5.75 | 247,016.00 | 8.38 | 4.44 | 12.70 | 6.77 | 32.04 | 26.95 | 14.24 | 6.87 | 0.5577 | 30.61 | 0.2614 | 18.54 | 7.02 | 1.31 | 121.92 | -0.3034 | 20.32 | -1.47 |
| Getinge AB | 2.70bn | 191.35m | 5.00bn | 11.86k | 28.02 | 1.98 | 15.09 | 1.85 | 8.39 | 8.39 | 118.22 | 118.80 | 0.6001 | 2.53 | 6.79 | 2,742,908.00 | 4.29 | 5.31 | 5.56 | 6.98 | 45.37 | 47.83 | 7.15 | 8.69 | 0.7569 | 11.47 | 0.2035 | 37.87 | 12.49 | 5.66 | -3.17 | -- | -0.3944 | 34.49 |
| ConvaTec Group PLC | 1.96bn | 119.32m | 5.77bn | 10.13k | 48.41 | 3.72 | 18.25 | 2.94 | 0.0507 | 0.0507 | 0.8333 | 0.6593 | 0.5865 | 2.57 | 6.14 | 168,870.80 | 3.57 | 2.36 | 4.18 | 2.73 | 56.04 | 55.03 | 6.08 | 4.34 | 0.8835 | 2.65 | 0.4367 | 127.29 | 3.37 | 3.18 | 107.15 | -6.93 | 12.37 | 31.41 |
| SCHOTT Pharma AG & Co KgaA | 888.16m | 155.06m | 5.81bn | 4.65k | 37.46 | 8.23 | 28.60 | 6.54 | 1.05 | 1.05 | 6.01 | 4.78 | -- | -- | -- | 194,928.30 | -- | -- | -- | -- | 35.23 | -- | 17.48 | -- | 1.08 | -- | 0.094 | -- | 9.43 | -- | 21.11 | -- | -- | -- |
| Amplifon SpA | 2.22bn | 152.14m | 6.98bn | 14.38k | 45.57 | 6.44 | 16.86 | 3.15 | 0.6898 | 0.6898 | 10.02 | 4.88 | 0.6219 | 20.99 | 10.38 | 157,179.50 | 4.27 | 4.31 | 6.16 | 5.81 | 23.56 | 59.01 | 6.86 | 7.28 | 0.4519 | 6.31 | 0.5795 | 34.26 | 6.65 | 10.66 | -12.21 | 9.08 | 12.68 | 15.68 |
| Carl Zeiss Meditec AG | 2.05bn | 271.41m | 8.69bn | 4.82k | 31.98 | -- | 108.57 | 4.23 | 3.10 | 3.10 | 23.45 | -- | -- | -- | -- | 434,177.70 | -- | 9.56 | -- | 11.72 | 57.35 | 57.84 | 13.28 | 13.15 | -- | -- | -- | 34.47 | 9.80 | 10.28 | -1.20 | 18.09 | 26.79 | 14.87 |
| Demant A/S | 2.95bn | 335.61m | 9.33bn | 21.62k | 28.07 | 7.65 | -- | 3.16 | 11.44 | 8.05 | 100.58 | 41.97 | 0.7431 | 2.05 | 5.88 | 1,037,923.00 | 8.46 | 8.27 | 12.20 | 13.23 | 73.72 | 74.14 | 11.38 | 11.34 | 0.9529 | 5.98 | 0.6075 | 0.00 | 13.89 | 10.00 | 12.23 | 6.96 | 8.80 | -- |
| Smith & Nephew plc | 5.08bn | 240.84m | 9.77bn | 18.45k | 40.49 | 2.04 | 11.27 | 1.92 | 0.2405 | 0.2405 | 5.07 | 4.78 | 0.5562 | 0.7522 | 4.33 | 240,099.80 | 2.64 | 4.10 | 3.29 | 4.99 | 68.82 | 71.39 | 4.74 | 8.02 | 0.72 | 4.84 | 0.3715 | 79.59 | 6.40 | 2.50 | 17.94 | -16.88 | 4.24 | -8.12 |
| Sonova Holding AG | 3.64bn | 600.50m | 15.23bn | 17.64k | 25.41 | 7.22 | 17.84 | 4.18 | 10.05 | 10.05 | 61.01 | 35.39 | 0.6887 | 2.44 | 7.04 | 206,996.80 | 11.56 | 10.87 | 14.70 | 13.94 | 71.77 | 71.75 | 16.78 | 17.80 | 0.9036 | 24.86 | 0.4646 | 34.54 | 11.13 | 7.16 | 1.08 | 9.79 | 9.89 | 12.09 |
| Sartorius Stedim Biotech SA | 2.66bn | 249.78m | 19.38bn | 10.60k | 74.33 | 4.88 | 38.21 | 7.27 | 2.73 | 2.73 | 29.11 | 41.57 | 0.4013 | 1.60 | 7.82 | 254,764.60 | 3.81 | 11.87 | 4.55 | 15.12 | 42.98 | 50.96 | 9.49 | 17.44 | 1.24 | 6.59 | 0.452 | 18.73 | -20.53 | 18.02 | -64.65 | 8.28 | 21.82 | 3.90 |
| Straumann Holding AG | 2.41bn | 246.07m | 19.61bn | 11.11k | 79.79 | 10.68 | 52.02 | 8.13 | 1.54 | 1.54 | 15.11 | 11.52 | 0.7204 | 1.81 | 4.29 | 217,105.00 | 7.37 | 10.68 | 9.86 | 13.63 | 74.15 | 74.95 | 10.23 | 15.15 | 1.43 | 6.72 | 0.1968 | 37.50 | 3.92 | 12.08 | -43.40 | -2.04 | 11.54 | 10.12 |
| Koninklijke Philips NV | 17.79bn | -777.69m | 22.62bn | 69.06k | -- | -- | 77.14 | 1.27 | -0.8649 | -0.8724 | 19.51 | -- | -- | -- | -- | 260,437.00 | -- | 0.3678 | -- | 0.5013 | 41.39 | 43.84 | -4.35 | 0.6049 | -- | 5.77 | -- | -- | 1.92 | 0.0529 | 71.87 | -- | -5.24 | -- |
| Coloplast A/S | 3.29bn | 640.18m | 23.12bn | 15.75k | 37.27 | 12.43 | 29.38 | 7.03 | 22.44 | 22.44 | 115.20 | 67.27 | 0.5794 | 2.40 | 5.99 | 1,593,232.00 | 11.28 | 20.45 | 17.11 | 29.69 | 66.74 | 67.91 | 19.47 | 21.73 | 0.3462 | 11.08 | 0.5885 | 91.08 | 8.51 | 8.29 | 1.64 | 4.46 | 13.15 | 5.59 |
Data as of Apr 30 2024. Currency figures normalised to Straumann Holding AG's reporting currency: Swiss Franc CHF
15.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 3.79m | 2.38% |
| UBS Asset Management Switzerland AGas of 02 Apr 2024 | 3.19m | 2.00% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2024 | 2.97m | 1.86% |
| Comgest SAas of 29 Dec 2023 | 2.96m | 1.86% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.59m | 1.63% |
| Vontobel Asset Management AGas of 31 Mar 2024 | 2.02m | 1.27% |
| Z�rcher Kantonalbank (Investment Management)as of 29 Feb 2024 | 1.87m | 1.17% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 1.86m | 1.17% |
| Morgan Stanley Investment Management Co.as of 31 Dec 2023 | 1.58m | 0.99% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 1.53m | 0.96% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
